AORT logo

Artivion, Inc. (AORT)

Profile

Full Name

Artivion, Inc.

Ticker

NYSE: AORT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 12, 1993

Indexes

Not included

Website

http://artivion.com

Employees

1600

Key Details

Price

$31.25(+0.03%)

Market cap

Last Dividend

$0.03

TTM Dividend yield

-

Annual revenue

$388.54M(+9.75% YoY)

Annual EPS

-$0.32(+57.33% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $31.25
    AORT price is $31.25

    30-Day Relative Volume

    0.70
    AORT 30-day relative volume is 0.70

    Price Performance

    Price Today change

    +0.03%
    AORT price is up +0.03% today

    Price YTD change

    +9.3%
    AORT price is up +9.3% since January 1st

    Price 1-year change

    +11.57%
    AORT price is up +11.57% year-on-year

    Price 3-year change

    +58.15%
    AORT price is up +58.15% over the past 3 years

    Price Range

    Price All-time high

    $44.82
    AORT price is currently -30.28% below its historical high of $44.82

    Price 3-year low

    $9.64
    AORT price is currently +224.17% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.33B
    AORT market capitalization is $1.33 billion

    Market cap 3-year change

    +67.76%
    AORT market capitalization is up +67.76% over the past 3 years

    Market cap All-time high

    $1.39B
    AORT market capitalization is currently -4.02% below its historical high of $1.39 billion

    Market cap sector rank

    77.56%
    AORT market capitalization is higher than 77.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.18%
    AORT shares outstanding is up +2.18% year-on-year

    Shares Outstanding 3-Year Change

    +6.08%
    AORT shares outstanding is up +6.08% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.69
    AORT beta is 0.69

    200-day SMA

    $27.82
    AORT price is currently +12.32% above its 200-day simple moving average

    50-day SMA

    $29.95
    AORT price is currently +4.34% above its 50-day simple moving average

    RSI

    55.74
    AORT 14-day relative strength index is 55.74

    Volume

    0.70
    AORT 30-day relative volume is 0.70

    ATR

    $0.87
    AORT average true range is $0.87

    10-day Historical Volatility

    29.03%
    AORT 10-day historical volatility is 29.03%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.03
    AORT last dividend was $0.03 per share, with an ex-dividend date of December 9, 2015

    Next Dividend

    -
    AORT next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    AORT annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    AORT annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    AORT annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    AORT annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    AORT annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    AORT annual dividend yield is unknown

    Other

    Payout ratio

    -
    AORT annual payout ratio value is unknown

    Dividends paid

    -
    AORT annual dividends paid value is unknown

    Free cash flow

    $11.05M
    AORT annual free cash flow is $11.05 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $388.54M
    AORT annual revenue is $388.54 million

    Revenue Analysts estimate

    $427.40M
    AORT annual revenue is currently -9.09% lower than the consensus analysts' forecast

    Revenue 1-year change

    +9.75%
    AORT annual revenue is up +9.75% year-on-year

    Revenue Sector rank

    70.97%
    AORT annual revenue is higher than 70.97% of companies in Healthcare sector

    EPS

    EPS

    -$0.32
    AORT annual earnings per share is -$0.32

    EPS Analysts estimate

    $0.55
    AORT annual earnings per share is currently -158.18% lower than the consensus analysts' forecast

    EPS 1-year change

    +57.33%
    AORT annual earnings per share is up +57.33% year-on-year

    EPS Sector rank

    72.26%
    AORT annual earnings per share is higher than 72.26% of companies in Healthcare sector

    Profit

    Gross profit

    $248.78M
    AORT annual gross profit is $248.78 million

    Gross margin

    64.03%
    AORT annual gross profit margin is 64.03%

    Operating profit

    $38.87M
    AORT annual operating income is $38.87 million

    Operating margin

    10.01%
    AORT annual operating profit margin is 10.01%

    Net income

    -$13.36M
    AORT annual net profit is -$13.36 million

    Net margin

    -3.44%
    AORT annual net profit margin is -3.44%

    Expenses

    Total expenses

    $349.66M
    AORT annual total expenses is $349.66 million

    Operating expenses

    $209.91M
    AORT annual total operating expenses is $209.91 million

    Cost of goods sold

    $139.76M
    AORT annual cost of goods sold is $139.76 million

    Selling, general & administrative expenses

    $181.46M
    AORT annual SGA is $181.46 million

    Depreciation and amortization

    $24.20M
    AORT annual depreciation & amortization is $24.20 million

    Interest expense

    $34.28M
    AORT annual interest expense is $34.28 million

    Income tax

    $5.84M
    AORT annual income tax is $5.84 million

    EBIT & EBITDA

    EBIT

    $26.76M
    AORT annual earnings before interest & taxes is $26.76 million

    EBITDA

    $50.97M
    AORT annual EBITDA is $50.97 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $789.10M
    AORT annual total assets is $789.10 million

    Non current assets

    $499.02M
    AORT annual long term assets is $499.02 million

    Current assets

    $290.08M
    AORT annual total current assets is $290.08 million

    Cash and cash equivalents

    $53.46M
    AORT annual cash & cash equivalents is $53.46 million

    Accounts receivable

    $79.46M
    AORT annual accounts receivable is $79.46 million

    Inventory

    $79.77M
    AORT annual inventory is $79.77 million

    Liabilities

    Total liabilities

    $512.90M
    AORT annual total liabilities is $512.90 million

    Long term liabilities

    $446.08M
    AORT annual total long term liabilities is $446.08 million

    Current liabilities

    $66.82M
    AORT annual total current liabilities is $66.82 million

    Accounts payable

    $17.97M
    AORT annual accounts payable is $17.97 million

    Debt

    Total debt

    $362.26M
    AORT annual total debt is $362.26 million

    Total debt 1-year change

    +1.09%
    AORT annual total debt is up +1.09% year-on-year

    Long term debt

    $356.97M
    AORT annual long term debt is $356.97 million

    Short term debt

    $5.29M
    AORT annual short term debt is $5.29 million

    Equity & Capital

    Shareholders equity

    $276.20M
    AORT annual stockholders equity is $276.20 million

    Book value

    $276.20M
    AORT annual book value is $276.20 million

    Retained earnings

    -$61.27M
    AORT annual retained earnings is -$61.27 million

    Working capital

    $223.26M
    AORT annual working capital is $223.26 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $22.24M
    AORT annual cash flow from operations is $22.24 million

    Cash from operations 1-year change

    +18.12%
    AORT annual cash flow from operations is up +18.12% year-on-year

    Cash from investing

    -$28.19M
    AORT annual cash flow from investing activities is -$28.19 million

    Cash from investing 1-year change

    -5515.14%
    AORT annual cash flow from investing activities is down -5515.14% year-on-year

    Cash from financing

    $2.20M
    AORT annual cash flow from financing activities is $2.20 million

    Cash from financing 1-year change

    +154.68%
    AORT annual cash flow from financing activities is up +154.68% year-on-year

    CAPEX

    CAPEX

    $11.19M
    AORT annual capital expenditures is $11.19 million

    CAPEX 1-year change

    +50.58%
    AORT annual capital expenditures is up +50.58% year-on-year

    Free Cash Flow

    Free cash flow

    $11.05M
    AORT annual free cash flow is $11.05 million

    Free cash flow 1-year change

    -3.05%
    AORT annual free cash flow is down -3.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    64.03%
    AORT annual gross profit margin is 64.03%

    Operating margin

    10.01%
    AORT annual operating profit margin is 10.01%

    Net margin

    -3.44%
    AORT annual net profit margin is -3.44%

    ROA & ROE

    ROA

    -1.69%
    AORT annual return on assets is -1.69%

    ROE

    -4.79%
    AORT annual return on equity is -4.79%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AORT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AORT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.54
    AORT price to book ratio is 4.54

    PB ratio Sector rank

    77.01%
    AORT price to book ratio is higher than 77.01% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.42
    AORT price to sales ratio is 3.42

    PS ratio Sector rank

    52.47%
    AORT price to sales ratio is higher than 52.47% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.66B
    AORT enterprise value is $1.66 billion

    Enterprise value Sector rank

    78.65%
    AORT enterprise value is higher than 78.65% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    47.05
    AORT EV/EBITDA is 47.05

    EV/EBITDA Sector rank

    96.83%
    AORT EV/EBITDA is higher than 96.83% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.34
    AORT annual current ratio is 4.34

    Quick ratio

    3.15
    AORT annual quick ratio is 3.15

    Leverage

    Debt to equity

    1.14
    AORT annual debt to equity ratio is 1.14

    Interest coverage ratio

    0.78
    AORT annual interest coverage ratio is 0.78

    Risk & Stability

    Piotroski F-Score

    4
    AORT piotroski f-score is 4

    Altman Z-Score

    2.40
    AORT altman z-score is 2.40

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Canaccord Genuity
    Buy
    May 6, 25 Needham
    Buy
    May 6, 25 JMP Securities
    Market Outperform
    Feb 25, 25 Stifel
    Buy
    Feb 25, 25 Needham
    Buy
    Feb 25, 25 Citizens Capital Markets
    Market Outperform
    Jan 28, 25 Needham
    Buy
    Dec 10, 24 JMP Securities
    Market Outperform
    Dec 9, 24 Needham
    Buy
    Nov 8, 24 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with AORT included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 15 years
    Ex Dividend dates calendar
    • What is the ticker symbol for Artivion, Inc.?
    • Does Artivion, Inc. pay dividends?
    • What sector is Artivion, Inc. in?
    • What industry is Artivion, Inc. in?
    • What country is Artivion, Inc. based in?
    • When did Artivion, Inc. go public?
    • Is Artivion, Inc. in the S&P 500?
    • Is Artivion, Inc. in the NASDAQ 100?
    • Is Artivion, Inc. in the Dow Jones?
    • When was Artivion, Inc.'s last earnings report?
    • When does Artivion, Inc. report earnings?

    What is the ticker symbol for Artivion, Inc.?

    The ticker symbol for Artivion, Inc. is NYSE:AORT

    Does Artivion, Inc. pay dividends?

    No, Artivion, Inc. does not pay dividends

    What sector is Artivion, Inc. in?

    Artivion, Inc. is in the Healthcare sector

    What industry is Artivion, Inc. in?

    Artivion, Inc. is in the Medical Devices industry

    What country is Artivion, Inc. based in?

    Artivion, Inc. is headquartered in United States

    When did Artivion, Inc. go public?

    Artivion, Inc.'s initial public offering (IPO) was on February 12, 1993

    Is Artivion, Inc. in the S&P 500?

    No, Artivion, Inc. is not included in the S&P 500 index

    Is Artivion, Inc. in the NASDAQ 100?

    No, Artivion, Inc. is not included in the NASDAQ 100 index

    Is Artivion, Inc. in the Dow Jones?

    No, Artivion, Inc. is not included in the Dow Jones index

    When was Artivion, Inc.'s last earnings report?

    Artivion, Inc.'s most recent earnings report was on May 5, 2025

    When does Artivion, Inc. report earnings?

    The next expected earnings date for Artivion, Inc. is August 8, 2025
    On this page